NCT01248754View on ClinicalTrials.gov

Positron Emission Tomography (PET) With 3,4-dihydroxy-6-18F-fluoro-L-enylalanine (18F-FDOPA) Study

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Cancer (High-grace Glioma)
Interventions
PROCEDURE

Surgical neuronavigation with 18F-DOPA PET imaging

Subjects will undergo preoperative 18F-FDOPA PET imaging, which will be used in neuronavigation software to guide resection of their high-grade glioma. Postoperative 18F-FDOPA PET imaging will be obtained to determine the extent of resection.

Trial Locations (3)

V7L 2L7

Lions Gate Hospital, North Vancouver

V5Z 1M9

Vancouver General Hospital, Vancouver

V5Z 4E6

BC Cancer Agency, Vancouver

All Listed Sponsors
lead

Alan Nichol

OTHER

NCT01248754 - Positron Emission Tomography (PET) With 3,4-dihydroxy-6-18F-fluoro-L-enylalanine (18F-FDOPA) Study | Biotech Hunter | Biotech Hunter